Organicell Regenerative Medicine Inc (QB)
-0.00023 (-1.39%)
Volume 67,550
Bid Price 0.015
Ask Price 100.00
News -
Day High 0.0172


52 Week Range


Day Low 0.016
Company Name Stock Ticker Symbol Market Type
Organicell Regenerative Medicine Inc (QB) OCEL OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.00023 -1.39% 0.01627 16:30:10
Open Price Low Price High Price Close Price Prev Close
0.016 0.016 0.0172 0.0165
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9 67,550 $ 0.01644 $ 1,110 - 0.01 - 0.054
Last Trade Time Type Quantity Stock Price Currency
12:45:44 550 $ 0.01627 USD


Draw Mode:

Organicell Regenerative Medicine Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 24.22M 1.49B 535.33M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
20.33k $ - - - -

more financials information »

Organicell Regenerative ... (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OCEL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01990.020.0160.0176746508,787-0.00363-18.24%
1 Month0.02550.02650.0160.0189521552,929-0.00923-36.2%
3 Months0.02550.05240.01360.02885471,001,561-0.00923-36.2%
6 Months0.03650.0540.01360.0314854829,079-0.02023-55.42%
1 Year0.03630.0540.010.0284707743,525-0.02003-55.18%
3 Years0.,145-0.04373-72.88%
5 Years0.130.48960.010.0337014723,669-0.11373-87.48%

Organicell Regenerative ... (QB) Description

We are a clinical-stage biopharmaceutical company principally focusing on the development of innovative biological therapeutics for the treatment of degenerative diseases and to provide other related services. Our proprietary products are derived from perinatal sources and manufactured to retain the naturally occurring microRNAs, without the addition or combination of any other substance or diluent. Our products and related services are principally used in the health care industry administered through doctors and clinics. The Company's leading product, ZofinTM (also known as OrganicellTM Flow). To date, the Company has obtained certain Investigation New Drug, and emergency IND approvals from the FDA, which authorized the Company to commence clinical trials or treatments in connection with the use of ZofinTM and related treatment protocols. The Company is pursuing efforts to complete ongoing clinical studies as well as obtaining approval to commence additional studies for other specific indications it has identified that the use of its products will provide more favorable and desired health related benefits for patients seeking alternative treatment options than are currently available.